The Importance of the New Peptides As of 2021, five AOMs have been authorized for long-term administration in the United States: Previously utilized AOMs such as orlistat, phentermine/topiramate, naltrexone/bupropion generally resulted in 3%7% greater weight loss than placebo
Final Thoughts: Why Your Gut Matters as Much as the Scale Acid reflux on GLP-1 medications isnt a sign of failure
GLP-1 medications, including well-known options like Ozempic, Wegovy and Zepbound, help people manage their weight and conditions like type 2 diabetes by slowing digestion, reducing appetite and supporting blood sugar control
Introducing Our Latest White Paper: Orforglipron: A Next-Generation Oral GLP-1 Agonist Were proud to share our newest research spotlighting Orforglipron, an innovative oral GLP-1 agonist poised to transform diabetes and obesity management
Multiple studies show that BPC 157 can increase NOS3, which is the enzyme needed for the synthesis of nitric oxide synthase